Insider · CIK 0001839248

Thompson Tamar

Reports to the SEC for 2 companies · CORAL GABLES, FL

sec.gov

Transactions

Companies

Filings

CIK

0001839248

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−3,773 sh	$31.50	−$119K	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−29.5K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−23.2K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director	DDisposition to Issuer	−18.1K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,414 sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−1,894 sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−5,468 sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,692 sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.5K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2026-02-27	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,413 sh	—	—	3,773
2025-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,413 sh	—	—	119,663
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+947 sh	—	—	2,360
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−947 sh	—	—	121,076
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+18.1K sh	—	—	116,555
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+5,468 sh	—	—	122,023
2025-06-10	RNAMAvidity Biosciences, Inc.A Award	Director	AAward	+6,692 sh	—	—	6,692
2025-06-10	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,034
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,413 sh	—	—	1,413
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,413 sh	—	—	98,440
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+23.2K sh	—	—	97,012
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+2,841 sh	—	—	99,853
2024-10-07	RNAMAvidity Biosciences, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$27.63	+$829K	30,000
2024-10-07	RNAMAvidity Biosciences, Inc.S Sale	Director	SSale	−30K sh	$44.98	−$1.35M	0
2024-10-07	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2024-06-13	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.5K sh	—	—	13,490
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director	AAward	+29.5K sh	—	—	69,524
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,240 sh	—	—	73,764
2023-06-15	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2022-06-15	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2021-01-11	RNAMAvidity Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000

Recent filings

Accepted (ET)
Jul 174
Thompson Tamar0001161697-26-000183
SEC(opens sec.gov)
Feb 274
Thompson Tamar0001193125-26-082311
SEC(opens sec.gov)
Dec 104
Thompson Tamar0001161697-25-000450
SEC(opens sec.gov)
Nov 244
Thompson Tamar0001161697-25-000423
SEC(opens sec.gov)
Jun 124
Thompson Tamar0001599901-25-000117
SEC(opens sec.gov)

Companies

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134